SARS-CoV-2 serology across scales: a framework for unbiased seroprevalence estimation incorporating antibody kinetics and epidemic recency

Serosurveys are a key resource for measuring SARS-CoV-2 cumulative incidence. A growing body of evidence suggests that asymptomatic and mild infections (together making up over 95% of all infections) are associated with lower antibody titers than severe infections. Antibody levels also peak a few we...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Saki, Peluso, Michael J., Hakim, Jill, Turcios, Keirstinne, Janson, Owen, Routledge, Isobel, Busch, Michael P., Hoh, Rebecca, Tai, Viva, Kelly, J. Daniel, Martin, Jeffrey N., Deeks, Steven G., Henrich, Timothy J., Greenhouse, Bryan, Rodríguez-Barraquer, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452112/
https://www.ncbi.nlm.nih.gov/pubmed/34545373
http://dx.doi.org/10.1101/2021.09.09.21263139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452112/
https://www.ncbi.nlm.nih.gov/pubmed/34545373
http://dx.doi.org/10.1101/2021.09.09.21263139

Ejemplares similares